Mankind Pharma Limited
Open MainLineCurrent GMP
₹121 (+11.20%)
Price Band
₹ 1026 – 1080
Lot Size
13
Issue Size
₹4326.36 Cr
Minimum Investment
₹14040 (13 Shares)
Listing Date
09 May 2023
Subscription
0.02x
About the Company
Incorporated in 1991,Mankind Pharma Limited specializes in the manufacturing and marketing of pharmaceutical formulations for both acute and chronic therapeutic areas, along with consumer healthcare products. The company is primarily oriented towards the domestic market, which accounted for 97.6% of its total revenue for the financial year 2022. It ranks as the fourth-largest pharmaceutical company in India based on domestic sales.
With a comprehensive marketing presence across India, Mankind Pharma operates 25 manufacturing facilities nationwide and boasts one of the largest distribution networks of medical representatives in the Indian pharmaceutical industry.
Promoters
Mankind Pharma Limited Promoters
Ramesh Juneja
Rajeev Juneja
Sheetal Arora
Ramesh Juneja Family Trust
Rajeev Juneja Family Trust
Prem Sheetal Family Trust
Promoters Holding
Holding Pre Issue
79.00%
Holding Post Issue
76.50%
Objects of the Issue
Mankind Pharma Ltd IPO is a 100% Offer for sale issue and all the proceeds will be received by the selling shareholders.
Address / Contact Info
Mankind Pharma Limited
208, Okhla Industrial Estate,
Phase-III, New Delhi 110 020
Phone : +91 11 4747 6600
Email : investors@mankindpharma.com
Website : www.mankindpharma.com
IPO Snapshot
IPO Timeline (Tentative)
IPO Open Date
Tuesday, 25 April 2023
IPO Close Date
Thursday, 27 April 2023
Basis of Allotment
Wednesday, 03 May 2023
Initiation of Refunds
Thursday, 04 May 2023
Credit of Shares to Demat
Friday, 05 May 2023
Listing Date
Tuesday, 09 May 2023 — NSE & BSE
Important Dates
Open Date
25 April 2023
Close Date
27 April 2023
Basis Of Allotment
03 May 2023
Listing Date
09 May 2023
Financial Performance (₹ in Crores)
| Particular | 31-Mar-20 | 31-Mar-21 | 31-Dec-21 | 31-Mar-22 | 31-Dec-22 |
|---|---|---|---|---|---|
| Assets | 5073.29 | 6372.63 | 8043.88 | 9147.74 | 9273.75 |
| Revenue | 5975.65 | 6385.38 | 6218.29 | 7977.58 | 6777.82 |
| Profit After Tax | 1056.15 | 1293.03 | 1260.24 | 1452.96 | 1015.98 |
| Net Worth | 3485.31 | 4722 | 5965.46 | 6155.23 | 7145.89 |
| Reserve & Surplus | 3436.34 | 4674.39 | 5916.86 | 6106.06 | 7094.12 |
| Total Borrowings | 126.92 | 234.53 | 268.7 | 868.03 | 167.93 |
EPS Pre
33.20%
EPS Post
0.00%
P/E Pre
32.50
P/E (Post Issue)
0.00x
Company Financial Information
KPI Information (₹ in Crores)
| Particular | The market capitalization of Mankind Pharma IPO is Rs 43263.6 Cr. |
|---|---|
| ROE % | 27.6 |
| ROCE % | 26.1 |
| Debt / Equity | 0 |
| RoNW % | 27.7 |
| PbW | 0 |
| Pat Margin % | 0 |
Return Ratio
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Anchor Investors | 12017652 | 30 | 0 |
| Qualified Institutions | 8011769 | 20 | 0 |
| Non-Institutional | 6008827 | 15 | 0 |
| BNII | 4005885 | 10 | 20543 |
| SNII | 2002942 | 5 | 10271 |
| Retail Investors | 14020596 | 35 | 1078507 |
| Total | 40058844 | 100 | 0 |
Subscription Status ( Tue, 25 Apr 23 11:25 AM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 8011769 | 393834103 | 49.16x |
| Non-Institutional | 6008827 | 22822761 | 3.8x |
| Retail Investors | 14020596 | 12856038 | 0.92x |
| Total | 28041192 | 429512902 | 15.32x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Peer Comparision
No Peer Comparision Available
Lot Size & Investment Details
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 13 | 14,040.00 |
| Retail (Max) | 14 | 182 | 196,560.00 |
| S-HNI (Min) | 15 | 195 | 210,600.00 |
| S-HNI (Max) | 71 | 923 | 996,840.00 |
| B-HNI (Min) | 72 | 936 | 1,010,880.00 |
Registrar
Kfin Technologies Limited
04067162222, 04079611000
reachus@kfintech.com
https://www.kfintech.com
Book Running Lead Managers
- IIFL Capital Services Limited
- Axis Capital Limited
- Jefferies India Private Limited
- J.P. Morgan India Private Limited
RHP Document
DRHP Document
Anchor Investors
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Mankind Pharma Limited is a Book-building IPO worth ₹4326.36 crores. The price band is ₹1026 to 1080 per share. The IPO opens on Tue, Apr 25, 2023 and closes on Thu, Apr 27, 2023. It will be listed on BSE and NSE. Kfin Technologies Limited is the registrar.
The Mankind Pharma Limited opens on Tue, Apr 25, 2023 and closes on Thu, Apr 27, 2023
Mankind Pharma Limited Price Band is ₹1026 to 1080.
Mankind Pharma Limited lot size is 13, and the minimum amount required for application is ₹14040.
The minimum investment for Mankind Pharma Limited is approximately ₹14040 based on the upper price band.
To apply for the Mankind Pharma Limited, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Thu, Apr 27, 2023. After submission, funds are blocked until the basis of allotment of Mankind Pharma Limited is finalised.
Mankind Pharma Limited issue size is ₹4326.36 crores.
Mankind Pharma Limited allotment date is Sat, Jun 27, 2026.
The registrar for Mankind Pharma Limited is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited website for IPO allotment status, refund processing, and other queries related to Mankind Pharma Limited through their official website or helpline.
The Mankind Pharma Limited GMP (Grey Market Premium) is ₹121 as of Tue, May 9, 2023. Based on the upper price band of ₹1080 per share, the estimated Mankind Pharma Limited listing price is ₹1201, indicating a potential listing gain of approximately 31% over the issue price.